Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-102,445
Closed -$5.4M 51
2021
Q4
$5.4M Sell
102,445
-1,246
-1% -$66.6K 1.43% 32
2021
Q3
$5.2M Sell
103,691
-3,284
-3% -$170K 1.52% 32
2021
Q2
$6.28M Buy
106,975
+597
+0.6% +$36.9K 1.79% 31
2021
Q1
$6.92M Sell
106,378
-2,322
-2% -$143K 2% 25
2020
Q4
$5.97M Sell
108,700
-2,302
-2% -$117K 1.87% 27
2020
Q3
$4.89M Sell
111,002
-10,069
-8% -$443K 1.82% 27
2020
Q2
$5.11M Sell
121,071
-2,512
-2% -$96.6K 1.82% 29
2020
Q1
$4.91M Sell
123,583
-25,735
-17% -$1.09M 2.1% 23
2019
Q4
$6.65M Buy
149,318
+739
+0.5% +$28.4K 1.54% 33
2019
Q3
$5.08M Buy
148,579
+401
+0.3% +$13.9K 1.23% 35
2019
Q2
$5.58M Sell
148,178
-3,839
-3% -$131K 1.37% 36
2019
Q1
$4.64M Sell
152,017
-403
-0.3% -$12.3K 1.13% 38
2018
Q4
$4.22M Buy
+152,420
New +$4.19M 1.17% 37

Other funds holding ACA

Kirr Marbach & Co's ACA Position: Q1 2022 in Review

Kirr Marbach & Co sold out of Arcosa (ACA) in Q1 2022, closing a stake of 102,445 shares — an estimated $5.4M sold.

Kirr Marbach & Co first reported a position in ACA in Q4 2018 and held it in 13 quarters. The position peaked at $6.92M in Q1 2021. 255 funds tracked by Wall St. Rank hold ACA as of Q1 2022.

  • Kirr Marbach & Co reported no remaining Arcosa position as of Q1 2022 after selling out during the quarter.
  • Kirr Marbach & Co sold 102,445 Arcosa shares in Q1 2022, an estimated $5.4M.
  • Kirr Marbach & Co first reported a position in Arcosa in Q4 2018 and held it in 13 quarters.
  • Kirr Marbach & Co's Arcosa position peaked at $6.92M in Q1 2021.
  • 255 funds tracked by Wall St. Rank held Arcosa as of Q1 2022.

Based on Kirr Marbach & Co's 13F filing for Q1 2022, filed 3 May 2022.